InvestorsHub Logo
Followers 4
Posts 382
Boards Moderated 0
Alias Born 05/10/2021

Re: Saving Grace post# 60

Sunday, 01/30/2022 4:23:24 PM

Sunday, January 30, 2022 4:23:24 PM

Post# of 278
Thanks for your post. I strolled over to this ticker to see exactly what the scam is. I don't know what the details of the scam are, and I read your post and I still don't understand. I know it is so shady the sun can't penetrate the canopy over this rip off. Do you have a few minutes to explain it more? I think I understand that they probably have to file these to keep their seedy actions legal. But what is the risk/strategy in the fact that Phoenixus owns Regnum? It sounds like Vyera acquired the rights from Cytodyn, then SevenScore acquired the rights from Vyera, and then SevenScore sold the rights to Regnum while becoming acquired by Phoenixus, which owns Regnum. My gut tells me this all to confuse people, provide protection, and create channels to funnel off money/assets. But how is it actually done?

You wrote:

"Front loaded sell off scam!

Quote:
THIS CONTRIBUTION AGREEMENT (this “Contribution Agreement”) is made effective as of January 3, 2022 (the “Effective Date”), notwithstanding
the actual date of execution hereof, by and among SevenScore Pharmaceuticals, LLC, a Delaware limited liability company (“SevenScore”), Regnum Corp., a
Nevada corporation (“Regnum”) and Phoenixus AG, a corporation organized under the laws of Switzerland and holder of (a) 99% of the issued and outstanding
shares of Regnum, and (b) 100% of the issued and outstanding membership interest units of SevenScore (“Phoenixus”)."

I found this:

"SevenScore Pharmaceuticals LLC entered into an agreement to acquire Regnum Corp. in a reverse merger transaction for $9.8 million.

SevenScore Pharmaceuticals LLC made a proposal to acquire Regnum Corp. (OTCPK:RGMP) from Phoenixus AG and others in a reverse merger transaction for $9.8 million on April 7, 2021. SevenScore Pharmaceuticals LLC entered into an agreement to acquire Regnum Corp. from Phoenixus AG and others in a reverse merger transaction on May 13, 2021. Phoenixus AG (“PAG”) owns approximately 98.9% stake in Regnum. Upon closing, membership interests in SevenScore will be converted into the right to receive an aggregate of 25.9 million shares of common stock of Regnum. Upon effectiveness of the Merger, (i) each share of Regnum Common Stock issued and outstanding and owned by PAG as of immediately prior thereto shall be cancelled and extinguished without any conversion thereof, and (ii) 22,730,409 shares of Regnum Common Stock will be owned by PAG as a result of conversion of SevenScore membership interests; (ii) 3,147,759 shares of RGMP Common Stock being owned by several other SevenScore members; and (iii) 250,000 shares of Regnum Common Stock being owned by the Regnum shareholders, other than PAG, prior to effectiveness of the Merger. The equity holders, or members, of SevenScore will receive a majority of the shares of common stock of Regnum in the merger. The completion of the Merger is subject to satisfaction to submit a Company Related Action Notification in accordance with Financial Industry Regulatory Authority (FINRA) Rule 6490. The board of directors of Regnum and SevenScore have unanimously approved the transaction. PAG, the majority shareholder of Regnum also approved the transaction."